Legal Opinion
Aramic LLC v. Revance Therapeutics, Inc.
District Court, N.D. California
Decided April 2, 2024No. 3:21-cv-09585Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ARAMIC LLC, et al., Case No. 21-cv-09585-AMO 8 Plaintiffs, ORDER GRANTING DEFENDANTS’ 9 v. MOTION TO DISMISS 10 REVANCE THERAPEUTICS, INC., et al., Re: Dkt. No. 65 Defendants. 11 12 13 This is a securities fraud case about the U.S. Food and Drug Administration’s review of a 14 drug developed by Revance Therapeutics, Inc. (“Revance”). Defendants’ motion to dismiss was 15 heard before this Court on August 10, 2023. Having read the papers filed by the parties and 16 carefully considered their arguments therein and those…
2Cases cited44 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- TSC Industries, Inc. v. Northway, Inc.Supreme Court of the United States · 1976
- Lee v. City Of Los AngelesCourt of Appeals for the Ninth Circuit · 2001
- Manzarek v. St. Paul Fire & Marine InsuranceCourt of Appeals for the Ninth Circuit · 2008
39 more not listed; retrieve them via the Exa API.